Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
For Use With (Application)
- (2)
- (970)
- (1)
- (23,544)
- (5)
- (1)
- (1)
- (67)
- (219)
- (4,424)
- (23)
- (1)
- (4)
- (2)
- (13)
- (21,453)
- (3)
- (4)
- (3)
- (1)
- (2)
- (4)
- (14)
- (71)
- (2)
- (2)
- (2)
- (1)
- (3)
- (2)
- (1)
- (3)
- (4)
- (1)
- (1)
- (1)
- (3)
- (254)
- (22,606)
- (1)
- (1)
- (2)
- (1)
- (13)
- (26,167)
- (256)
- (32)
- (3)
- (708)
- (14)
- (2)
- (1)
- (8)
- (1)
- (5)
- (1)
- (108)
- (1)
- (3,782)
- (1,408)
- (3)
- (4)
- (2)
- (5)
- (1)
- (1)
- (1)
- (1)
- (14)
- (138)
- (48)
- (6)
- (17)
- (2)
- (1)
- (4)
- (81)
- (12)
- (2)
- (3)
- (80)
- (4)
- (113)
- (96)
- (19)
- (1)
- (1)
- (4)
- (1)
- (1,522)
- (2)
- (1)
- (3)
- (18)
- (48)
- (3)
- (1)
- (2)
- (9)
- (27)
- (2)
- (199)
- (1)
- (4)
- (1)
- (2)
- (114)
- (44)
- (2)
- (1)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (23,711)
- (6)
- (3)
- (1)
- (1)
- (63)
- (6)
- (2)
- (7)
- (5)
- (1)
- (2)
- (1)
- (1)
- (6,728)
- (6)
- (4)
- (1)
- (3)
- (1)
- (3)
- (2)
- (13)
- (17)
- (1)
- (3)
- (3)
- (4)
- (25,927)
- (240)
- (1)
- (3)
Recombinant
- (286)
- (2)
- (61,742)
- (1)
Form
- (15)
- (1)
- (2)
- (45,214)
- (5,693)
- (245)
- (168)
- (56)
- (3,364)
Species
- (2)
- (1)
- (2)
- (1)
- (21)
- (558)
- (96)
- (2)
- (1)
- (1)
- (2)
- (1)
- (27)
- (1)
- (8)
- (15)
- (1)
- (72)
- (1)
- (1,042)
- (1)
- (3)
- (16)
- (1)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (4)
- (1)
- (1)
- (26,017)
- (5)
- (1)
- (4)
- (582)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (14)
- (32)
- (24)
- (1)
- (2)
- (16)
- (120)
- (9)
- (2)
- (1)
- (2)
- (2)
- (2)
- (23)
- (5)
- (3)
- (3)
- (2)
- (14)
- (23,575)
- (1)
- (48)
Conjugate
- (7)
- (1)
- (3)
- (18)
- (2)
- (62)
- (1)
- (4)
- (2)
- (9)
- (59)
- (1)
- (2)
- (3)
- (1)
- (391)
- (1)
- (3)
- (2)
- (1)
- (1)
- (1)
- (3)
- (2)
- (6)
- (19)
- (7)
- (2)
- (2)
- (3)
- (45)
- (1)
- (1)
- (1)
- (2)
- (5)
- (1)
- (1)
- (1)
- (1)
- (2)
- (8)
- (2)
- (3)
- (38,945)
- (1)
- (11)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Keyword Search:
Clear search
6,421
–
6,435
of
115,846
results
6,421
6,422
6,423
Novus Biologicals™ PDRG1 Protein
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Highly purified. Generating reliable and reproducible results.
| Regulatory Status | RUO |
|---|---|
| Purification Method | SDS-PAGE |
| Purity or Quality Grade | >90% |
| Conjugate | Unconjugated |
| Common Name | PDRG1 |
| Molecular Weight (g/mol) | 17.6kDa |
| Formulation | Liquid. In 20mM Tris-HCl buffer (pH 8.0) containing 0.2M NaCl, 5mM DTT, 20% glycerol |
| Storage Requirements | Store at -80°C. Avoid freeze-thaw cycles. |
| Concentration | 0.5mg/mL |
| For Use With (Application) | SDS-PAGE |
6,424
| Purity or Quality Grade | >90% as determined by SDS-PAGE. >90% as determined by SEC-HPLC. |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 6 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 136.26 kDa |
| Common Name | SARS-CoV-2 Spike (trimer) Protein |
| Activity | Immobilized human ACE2 protein (mFc tag) at 2 μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 (BA.4) Spike S1+S2 trimer Protein (ECD, His Tag), the EC50 is 8-32 ng/mL. |
| Endotoxin Concentration | <1.0 EU/μg |
| Storage Requirements | -20°C, Avoid Freeze/Thaw Cycles |
| Sequence | SARS-CoV-2 spike S1/S2 (Accession # YP_009724390.1) with variant BA.4 mutations expressed with the bacteriophage T4 fibritin and a C-terminal His-tag. Full sequence information available in Product Specfic Information section. |
| Concentration | 0.25 mg/mL |
| Expression System | HEK293 cells |
| For Use With (Application) | Control,ELISA Standard,Binding Assay |
| Name | SARS-CoV-2 Spike Protein S1/S2 (BA.4) His-tag, trimer |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV-2 |
| Product Type | Protein |
| Formulation | 25mM sodium citrate with 5% mannitol, 200mM NaCl, 5% trehalose, 0.01% Tween 80 and no preservative; pH 6 |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
6,425
| Purity or Quality Grade | >90% as determined by SDS-PAGE. >90% as determined by SEC-HPLC. |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 6 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 136.57 kDa |
| Common Name | SARS-CoV-2 Spike (trimer) Protein |
| Activity | Immobilized Human ACE2 (mFc tag) at 2 μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 (BA.2.12.1) Spike S1+S2 trimer Protein (ECD, His Tag), the EC50 is 5-20 ng/mL. |
| Endotoxin Concentration | <1.0 EU/μg |
| Storage Requirements | -20°C, Avoid Freeze/Thaw Cycles |
| Sequence | SARS-CoV-2 spike S1/S2 (Accession # YP_009724390.1) with variant B.2.12.1 mutations expressed with the bacteriophage T4 fibritin and a C-terminal His-tag. Full sequence information available in Product Specfic Information section. |
| Concentration | 0.25 mg/mL |
| Expression System | HEK293 cells |
| For Use With (Application) | Control,ELISA Standard,Binding Assay |
| Name | SARS-CoV-2 Spike Protein S1/S2 (BA.2.12.1) His-tag, trimer |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV-2 |
| Product Type | Protein |
| Formulation | 25mM sodium citrate with 5% mannitol, 200mM NaCl, 5% trehalose, 0.01% Tween 80 and no preservative; pH 6 |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
6,426
Novus Biologicals™ Recombinant Human Sorbitol Dehydrogenase Protein
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Highly purified and high bioactivity. Generating reliable and reproducible results.
| Purity or Quality Grade | >90%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain |
|---|---|
| Conjugate | Unconjugated |
| Gene Alias | EC 1.1.1, EC 1.1.1.14, L-iditol 2-dehydrogenase, sorbitol dehydrogenase, SORD1 |
| Biological Activity | Specific activity is > 15 units/mg, and is defined as the amount ofenzyme that catalyze the reduction 1.0 umole of D-fructose to D-sorbitol per minute atpH 7.5 at 37C. |
| Common Name | Sorbitol Dehydrogenase |
| Molecular Weight (g/mol) | TMW: 38.3kDa |
| Gene ID (Entrez) | 6652 |
| Formulation | 20mM Tris-HCl buffer(pH 8.5) containing 10% glycerol, 1mM DTT |
| Storage Requirements | Store at 4°C short term. Aliquot and store at −20°C long term. Avoid freeze-thaw cycles. |
| Concentration | 0.5mg/mL |
| For Use With (Application) | SDS-PAGE |
| Recombinant | Recombinant |
6,427
6,428
6,429
Novus Biologicals™ ACADVL Protein
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Highly purified. Generating reliable and reproducible results.
| Regulatory Status | RUO |
|---|---|
| Purification Method | Protein |
| Purity or Quality Grade | >90% |
| Conjugate | Unconjugated |
| Common Name | ACADVL |
| Molecular Weight (g/mol) | 68.5kDa |
| Gene ID (Entrez) | 37 |
| Formulation | In 20mM Tris-HCl buffer (pH 8.0) containing 10% glycerol 1mM DTT, 1mM EDTA, 0.1M NaCl. |
| Immunogen | MGSSHHHHHH SSGLVPRGSH MAGGAAQLAL DKSDSHPSDA LTRKKPAKAE SKSFAVGMFK GQLTTDQVFP YPSVLNEEQT QFLKELVEPV SRFFEEVNDP AKNDALEMVE ETTWQGLKEL GAFGLQVPSE LGGVGLCNTQ YARLVEIVGM HDLGVGITLG AHQSIGFKGI LLFGTKAQKE KYLPKLASGE TVAAFCLTEP SSGSDAASIR TSAVPSPCGK YYTLNGSKLW ISNGGLADIF TVFAKTPVTD PATGAVKEKI TAFVVERGFG GITHGPPEKK MGIKASNTAE VFFDGVRVPS ENVLGEVGSG FKVAMHILNN GRFGMAAALA GTMRGIIAKA VDHATNRTQF GEKIHNFGLI QEKLARMVML QYVTESMAYM VSANMDQGAT DFQIEAAISK IFGSEAAWKV TDECIQIMGG MGFMKEPGVE RVLRDLRIFR IFEGTNDILR LFVALQGCMD KGKELSGLGS ALKNPFGNAG LLLGEAGKQL RRRAGLGSGL SLSGLVHPEL SRSGELAVRA LEQFATVVEA KLIKHKKGIV NEQFLLQRLA DGAIDLYAMV VVLSRASRSL SEGHPTAQHE KMLCDTWCIE AAARIREGMA ALQSDPWQQE LYRNFKSISK ALVERGGVVT SNPLGF |
| Storage Requirements | Store at -80°C. Avoid freeze-thaw cycles. |
| Concentration | 0.5mg/mL |
| For Use With (Application) | ELISA,SDS-PAGE |
| Source | Human |
6,430
6,431
6,432
| Conjugate | Unconjugated |
|---|---|
| Gene Alias | FGF10, FGF-10, fibroblast growth factor 10, Keratinocyte growth factor 2, KGF2, KGF-2, produced by fibroblasts of urinary bladder lamina propria |
| Molecular Weight (g/mol) | 19-23 kDa, under reducing conditions. |
| Gene ID (Entrez) | 2255 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in MOPS, Na2SO4, EDTA and DTT with Trehalose. |
| Reconstitution | Reconstitute at 250 μg/mL in water. |
| Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | FGF-10 |
| Source | E. coli-derived human FGF-10 protein Prorietary, engineered based on O15520. |
6,433
R&D Systems™ Recombinant Mouse Cadherin-4/R-Cadherin Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
6,434
R&D Systems™ Recombinant Human IL-10 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 18.6 kDa |
| Gene Symbol | IL10 |
| Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Storage Requirements | Manual defrost freezer; Avoid repeated freeze-thaw cycles; 12 mo. from receipt, -20 to -70°C as supplied; 1 mo, 2 to 8°C under sterile conditions after reconstitution; 3 mo, -20 to -70°C under sterile conditions after reconstitution |
| For Use With (Application) | Bioactivity |
| Source | <EM>Spodoptera frμgiperda</EM>, <EM>Sf</EM> 21 (baculovirus)-derived human IL-10 protein Ser19-Asn178 |
| Accession Number | P22301 |
| Regulatory Status | RUO |
| Gene Alias | CSIF, CSIFMGC126450, Cytokine synthesis inhibitory factor, GVHDS, IL10, IL10A, IL-10MGC126451, interleukin 10, interleukin-10, TGIF |
| Gene ID (Entrez) | 3586 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. *1 mg pack size (01M) is supplied as a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
| Reconstitution | Reconstitute at 50 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
| Cross Reactivity | IL-10 |
| Species | Human |
6,435
R&D Systems™ Recombinant Human VISTA/B7-H5/PD-1H His-tag Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.